Skip to main content

Table 4 Multivariable logistic regressions (associations between therapy received and cohort/other covariates)

From: Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points

 

Adjusted odds ratio (95% CI) of therapy received

Therapy received

Polytherapy

High dose

Polytherapy and high dose

Model size

n = 400

n = 400

n = 312

Cohort (base: 1st)

1.81 (1.08–3.02)*

-

2.14 (1.10–4.17)*

Gender (base: male)

-

-

-

Age (year)

-

-

-

Ethnicity (base: Australian)

-

-

-

Adm. in last 12 m (base: one or two):

   

- three or four

1.77 (0.87–3.60)

-

2.28 (0.97–5.35)

- five or more

7.52 (2.92–19.4)*

-

5.30 (1.57–17.8)*

Hospital stay (day)

^

^

^

Primary diagn. (base: schizophrenia):

   

- bipolar disorder

0.19 (0.08–0.47)*

-

0.26 (0.08–0.80)*

- other psychotic disorder

0.33 (0.14–0.75)*

-

0.33 (0.11–1.00)

- other

0.40 (0.21–0.76)*

-

0.40 (0.17–0.91)*

Comorbid substance use disorder

-

-

-

Involuntary treatment

3.95 (2.31–6.77)*

2.22 (1.34–3.66)*

3.18 (1.61–6.29)*

Previous clozapine trial

5.80 (2.43–13.8)*

2.19 (1.10–4.38)*

5.58 (2.04–15.3)*

  1. CI confidence interval, * p < 0.05; hyphen = excluded from multivariable model at p ≥ 0.50; ^ = excluded due to multicorreality; m months, diagn. diagnosis, adm. admissions